Dov Amar

Nasus Pharma Ltd. is a pharmaceutical company based in Tel Aviv, Israel. The Israeli company specializes in developing intranasal powder products to assist patients in acute emergency situations such as opioid overdose and anaphylactic shock. The private company's portfolio includes intranasal naloxone and intranasal epinephrine, as well as several preclinical programs. Nasus Pharma's unique patented technology creates a unique combination of two homogenous particle populations. The company has presented clinical results at various conferences and are dedicated to addressing acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo.